参考文献/References:
[1].Zhang X,Liu L,Chen WC,et al. Gestational leucylation suppresses embryonic T‐box transcription factor 5 signal and causes congenital heart disease[J]. Adv Sci(Weinh),2022,9(15):2201034.
[2].Zhang R,Guo L,Zhao D,et al. Maternal B-vitamin intake and B-vitamin supplementation during pregnancy in relation to neonatal congenital heart defects:a case-control study with propensity score matching[J]. Eur J Clin Nutr,2021,75(5):782-791.
[3].Tyagi R,Verma S,Dash N,et al. Folate deficiency:a possible association with congenital heart defects[J]. Indian J Pediatr,2022,89(10):1013-1015.
[4].Elizabeth KE,Praveen SL,Preethi NR,et al. Folate,vitamin B12,homocysteine and polymorphisms in folate metabolizing genes in children with congenital heart disease and their mothers[J]. Eur J Clin Nutr,2017,71(12):1437-1441.
[5].Gildestad T,Bj?rge T,Haaland ?A,et al. Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway,1999-2013[J]. Br J Nutr,2020,124(3):316-329.
[6].Feng Y,Zhao LZ,Hong L,et al. Alteration in methylation pattern of GATA-4 promoter region in vitamin A-deficient offspring’s heart[J]. J Nutr Biochem,2013,24(7):1373-1380.
[7].Sugrue KF,Zohn IE. Reduced maternal vitamin A status increases the incidence of normal aortic arch variants[J]. Genesis,2019,57(11-12):e23343.
[8].Kominiarek MA,Rajan P. Nutrition recommendations in pregnancy and lactation[J]. Med Clin North Am,2016,100(6):1199-1215.
[9].Bj?rke-Monsen AL,Varsi K,Sakkestad ST,et al. Assessment of vitamin B6 status in never-pregnant,pregnant and postpartum women and their infants[J]. Eur J Nutr,2023,62(2):867-878.
[10].Pusceddu I,Herrmann W,Kleber ME,et al. Subclinical inflammation,telomere shortening,homocysteine,vitamin B6,and mortality:the ludwigshafen risk and cardiovascular health study[J]. Eur J Nutr,2020,59(4):1399-1411.
[11].Minovi? I,Kieneker LM,Gansevoort RT,et al. Vitamin B6,inflammation,and cardiovascular outcome in a population-based cohort:The Prevention of Renal and Vascular End-Stage Disease (PREVEND) study[J]. Nutrients,2020,12(9):2711.
[12].Jayedi A,Zargar MS. Intake of vitamin B6,folate,and vitamin B12 and risk of coronary heart disease:a systematic review and dose-response meta-analysis of prospective cohort studies[J]. Crit Rev Food Sci Nutr,2019,59(16):2697-2707.
[13].Zhang P,Tsuchiya K,Kinoshita T,et al. Vitamin B6 prevents IL-1β protein production by inhibiting NLRP3 inflammasome activation[J]. J Biol Chem,2016,291(47):24517-24527.
[14].Adams JB,Kirby JK,Sorensen JC,et al. Evidence based recommendations for an optimal prenatal supplement for women in the US:vitamins and related nutrients[J]. Matern Health Neonatol Perinatol,2022,8(1):4.
[15].Czeizel AE,Puhó E,Bánhidy F,et al. Oral pyridoxine during pregnancy:potential protective effect for cardiovascular malformations[J]. Drugs R D,2004,5(5):259-269.
[16].Caffrey A,McNulty H,Irwin RE,et al. Maternal folate nutrition and offspring health:evidence and current controversies[J]. Proc Nutr Soc,2019,78(2):208-220.
[17].Mao B,Qiu J,Zhao N,et al. Maternal folic acid supplementation and dietary folate intake and congenital heart defects[J]. PLoS One,2017,12(11):e0187996.
[18].Newman RD,Parise M,Nahlen B. Folic acid antagonists during pregnancy and risk of birth defects[J]. N Engl J Med,2001,344(12):934.
[19].Feng Y,Wang S,Chen R,et al. Maternal folic acid supplementation and the risk of congenital heart defects in offspring:a meta-analysis of epidemiological observational studies[J]. Sci Rep,2015,5:8506.
[20].Obeid R,Holzgreve W,Pietrzik K. Folate supplementation for prevention of congenital heart defects and low birth weight:an update[J]. Cardiovasc Diagn Ther,2019,9(suppl 2):S424-S433.
[21].Liu S,Joseph KS,Luo W,et al. Effect of folic acid food fortification in Canada on congenital heart disease subtypes[J]. Circulation,2016,134(9):647-655.
[22].Boot MJ,Steegers-Theunissen RP,Poelmann RE,et al. Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro[J]. Dev Dyn,2003,227(2):301-308.
[23].Xuan C,Li H,Zhao JX,et al. Association between MTHFR polymorphisms and congenital heart disease:a meta-analysis based on 9,329 cases and 15,076 controls[J]. Sci Rep,2014,4:7311.
[24].Zhao JY,Qiao B,Duan WY,et al. Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations[J]. Eur Heart J,2014,35(11):733-742.
[25].Christensen KE,Rohlicek CV,Andelfinger GU,et al. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects[J]. Hum Mutat,2009,30(2):212-220.
[26].Zhao JY,Yang XY,Shi KH,et al. A functional variant in the cystathionine β-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population[J]. Cell Res,2013,23(2):242-253.
[27].Czeizel AE,Dudás I,Vereczkey A,et al. Folate deficiency and folic acid supplementation:the prevention of neural-tube defects and congenital heart defects[J]. Nutrients,2013,5(11):4760-4775.
[28].Qu Y,Lin S,Zhuang J,et al. First‐trimester maternal folic acid supplementation reduced risks of severe and most congenital heart diseases in offspring:a large case‐control study[J]. J Am Heart Assoc,2020,9(13):e015652.
[29].Wang D,Jin L,Zhang J,et al. Maternal periconceptional folic acid supplementation and risk for fetal congenital heart defects[J]. J Pediatr,2022,240:72-78.
[30].Verkleij-Hagoort AC,van Driel LM,Lindemans J,et al. Genetic and lifestyle factors related to the periconception vitamin B12 status and congenital heart defects:a Dutch case-control study[J]. Mol Genet Metab,2008,94(1):112-119.
[31].Rosenquist TH. Folate,homocysteine and the cardiac neural crest[J]. Dev Dyn,2013,242(3):201-218.
[32].Wang J,Zhao JY,Wang F,et al. A genetic variant in vitamin B12 metabolic genes that reduces the risk of congenital heart disease in Han Chinese populations[J]. PLoS One,2014,9(2):e88332.
[33].Shaw GM,O’Malley CD,Wasserman CR,et al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring[J]. Am J Med Genet,1995,59(4):536-545.
[34].Mokhtar WA,Fawzy A,Allam RM,et al. Maternal vitamin D level and vitamin D receptor gene polymorphism as a risk factor for congenital heart diseases in offspring;An Egyptian case-control study[J]. Genes Dis,2018,6(2):193-200.
[35].Kwon HJ. Vitamin D receptor signaling is required for heart development in zebrafish embryo[J]. Biochem Biophys Res Commun,2016,470(3):575-578.
[36].Koster MPH,van Duijn L,Krul-Poel YHM,et al. A compromised maternal vitamin D status is associated with congenital heart defects in offspring[J]. Early Hum Dev,2018,117:50-56.
[37].Brade T,Pane LS,Moretti A,et al. Embryonic heart progenitors and cardiogenesis[J]. Cold Spring Harb Perspect Med,2013,3(10):a013847.
[38].Saraf R,Morton SM,Camargo CA,et al. Global summary of maternal and newborn vitamin D status-a systematic review[J]. Matern Child Nutr,2016,12(4):647-668.
[39].吴桂琴. 孕母维生素D水平与新生儿先天性心脏病的相关性研究[D]. 兰州: 兰州大学,2023.
[40].中华预防医学会儿童保健分会. 中国儿童维生素A、维生素D临床应用专家共识[J]. 中国儿童保健杂志,2024,32(4):349-358,361.
[41].Azzi A. Many tocopherols,one vitamin E[J]. Mol Aspects Med,2018,61:92-103.
[42].Ziegler M,Wallert M,Lorkowski S,et al. Cardiovascular and metabolic protection by vitamin E:a matter of treatment strategy?[J]. Antioxidants(Basel),2020,9(10):935.
[43].Ley SH,Hanley AJ,Sermer M,et al. Lower dietary vitamin E intake during the second trimester is associated with insulin resistance and hyperglycemia later in pregnancy[J]. Eur J Clin Nutr,2013,67(11):1154-1156.
[44].Beckhaus AA,Garcia-Marcos L,FornoE,et al. Maternal nutrition during pregnancy and risk of asthma,wheeze,and atopic diseases during childhood:a systematic review and meta-analysis[J]. Allergy,2015,70(12):1588-1604.
[45].Bártfai L,Bártfai Z,Nedeczky I,et al. Rate of preterm birth in pregnant women with vitamin E treatment:a population-based study[J]. J Matern Fetal Neonatal Med,2012,25(6):575-580.
[46].Smedts HP,de Vries JH,Rakhshandehroo M,et al. High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring[J]. BJOG,2009,116(3):416-423.
[47].Wang T,Xu L. Circulating vitamin E levels and risk of coronary artery disease and myocardial infarction:a Mendelian randomization study[J]. Nutrients,2019,11(9):2153.
相似文献/References:
[1]郭琳娟,洪葵.成人先天性心脏病心律失常的诊断和治疗进展[J].心血管病学进展,2015,(6):752.[doi:10.3969/j.issn.1004-3934.2015.06.024]
GUO Linjuan,HONG Kui.Advances in Diagnosis and Treatment of Adult Congenital Heart
Disease with Arrhythmia[J].Advances in Cardiovascular Diseases,2015,(1):752.[doi:10.3969/j.issn.1004-3934.2015.06.024]
[2]朱峰,陈铀.先天性心脏病相关肺动脉高压的治疗进展[J].心血管病学进展,2019,(6):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
ZHU Feng,CHEN You.Congenital Heart Disease-related Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(1):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
[3]黄金秋 路发文 赵永康 陈宇雨 史红蕊 王萍 杨菊仙.先天性心脏病患儿营养状况及其危险因素分析[J].心血管病学进展,2020,(12):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
HUANG Jinqiu,LU Fawen,ZHAO Yongkang,et al.Nutritional Status in Children with Congenital Heart Disease and the Influential Factors[J].Advances in Cardiovascular Diseases,2020,(1):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
[4]周玲梅 张文倩 张智伟.体-肺动脉分流术在建立先天性心脏病动物模型中的应用进展[J].心血管病学进展,2021,(7):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
ZHOU Lingmei,ZHANG Wenqian,ZHANG Zhiwei.Application Progress of Systemic Pulmonary Arterial Shunt in Animal Model of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2021,(1):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
[5]林锡祥 杨菲菲 陈煦 何昆仑.人工智能赋能医学影像在先天性心脏病医学诊治中的研究进展[J].心血管病学进展,2022,(12):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
LIN Xixiang,YANG Feifei,CHEN Xu,et al.Artificial Intelligence Medical Imaging Technology in Medical Imaging of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2022,(1):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
[6]刘晓旭 莫绪明.先天性心脏病患儿心肺转流术后肠道损伤机制及治疗进展[J].心血管病学进展,2023,(6):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]
LIU Xiaoxu,MO Xuming.Mechanism and Treatment of Intestinal Injury After Cardiopulmonary Bypass in Children with Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2023,(1):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]
[7]董捷 杜楚豪 董硕 刘顺 徐海涛 孙阳雪 邹孟轩 孙家树 李守军 杨克明 闫军.Uhl畸形诊断与治疗研究进展[J].心血管病学进展,2023,(8):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
DONG Jie DU Chuhao DONG ShuoLIU Shun,XU HaitaoSUN YangxueZOU MengxuanSUN JiashuLI Shoujun,YANG Keming,et al.Diagnosis and Treatment for Uhls Anomaly[J].Advances in Cardiovascular Diseases,2023,(1):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
[8]陈颖慧 冯奕源 冯炜琦 吴逸卓 鲁亚南 于昱.血管发育异常的先天性心脏病患儿中Vav2基因突变的筛查和功能分析[J].心血管病学进展,2023,(8):757.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.019]
CHEN Yinghui,FENG Yiyuan,FENG Weiqi,et al.Identification and Functional Analysis of Vav2 Novel Variant in Congenital Heart Diseases with Vascular Malformation[J].Advances in Cardiovascular Diseases,2023,(1):757.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.019]
[9]李强强 顾虹.中国儿童肺动脉高压诊治现状[J].心血管病学进展,2024,(1):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]
LI Qiangqiang,GU Hong.Current Status of Diagnosis and Treatment of Pulmonary Hypertension in Chinese Children[J].Advances in Cardiovascular Diseases,2024,(1):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]
[10]李思聪 罗勤 赵智慧 赵青 柳志红.房间隔缺损相关肺动脉高压机制及治疗进展[J].心血管病学进展,2024,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]
LI Sicong,LUO Qin,ZHAO Zhihui,et al.Pathogenesis and Treatment of Pulmonary Hypertension Associated with Atrial Septal Defect[J].Advances in Cardiovascular Diseases,2024,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]